摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

non-8-yn-1-yl methanesulfonate | 1109217-81-3

中文名称
——
中文别名
——
英文名称
non-8-yn-1-yl methanesulfonate
英文别名
Non-8-ynyl methanesulfonate
non-8-yn-1-yl methanesulfonate化学式
CAS
1109217-81-3
化学式
C10H18O3S
mdl
——
分子量
218.317
InChiKey
RKDKRAQITYWKNF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    344.7±25.0 °C(Predicted)
  • 密度:
    1.066±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    14
  • 可旋转键数:
    8
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.8
  • 拓扑面积:
    51.8
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    non-8-yn-1-yl methanesulfonatecopper(l) iodide 、 trans-bis(triphenylphosphine)palladium dichloride 、 10% palladium hydroxide on charcoal 、 palladium 10% on activated carbon 、 氢气caesium carbonate三乙胺 作用下, 以 四氢呋喃N,N-二甲基甲酰胺乙腈 为溶剂, 25.0~80.0 ℃ 、103.42 kPa 条件下, 反应 3.5h, 生成 tert-butyl N-tert-butoxycarbonyl-N-[9-[2-(2,6-dioxo-3-piperidyl)-1,3-dioxoisoindolin-4-yl]nonyl]carbamate
    参考文献:
    名称:
    IRAK DEGRADERS AND USES THEREOF
    摘要:
    本发明提供了化合物、其组合物以及使用这些化合物的方法。
    公开号:
    US20190192668A1
  • 作为产物:
    描述:
    3-壬炔-1-醇 在 sodium hydride 、 三乙胺 作用下, 以 二氯甲烷乙二胺 、 mineral oil 为溶剂, 反应 15.0h, 生成 non-8-yn-1-yl methanesulfonate
    参考文献:
    名称:
    Phase Separation As a Strategy Toward Controlling Dilution Effects in Macrocyclic Glaser-Hay Couplings
    摘要:
    Macrocycles are abundant in numerous chemical applications, however the traditional strategy for the preparation of these compounds remains cumbersome and environmentally damaging; involving tedious reaction set-ups and extremely dilute reaction media. The development of a macrocyclization strategy conducted at high concentrations is described which exploits phase separation of the catalyst and substrate, as a strategy to control dilution effects. Sequestering a copper catalyst in a highly polar and/or hydrophilic phase can be achieved using a hydrophilic ligand, T-PEG(1900), a PEGylated TMEDA derivative. Similarly, phase separation is possible when suitable copper complexes are soluble in PEG(400), a green and efficient solvent which can be utilized in biphasic mixtures for promoting macrocyclization at high concentrations. The latter phase separation technique can be exploited for the synthesis of a wide range of industrially relevant macrocycles with varying ring sizes and functional groups.
    DOI:
    10.1021/ja208902t
点击查看最新优质反应信息

文献信息

  • Diethylzinc-Mediated Radical 1,2-Addition of Alkenes and Alkynes
    作者:Xin Li、Songtao He、Qiuling Song
    DOI:10.1021/acs.orglett.1c00669
    日期:2021.4.16
    A novel diethylzinc-mediated radical 1,2-addition of perfluoroalkyl iodides to unactivated alkenes and alkynes is presented, which demonstrates a novel way to generate an ethyl difluoroacetate radical. This method is highly efficient and gives full conversions of the substrates, high yields of the products, and negligible byproducts and requires no column chromatography purifications. The mild conditions
    提出了一种新颖的由二乙基介导的全氟烷基与非活化烯烃和炔烃进行的1,2-基自由基加成反应,这表明了一种生成二氟乙酸乙酯基团的新方法。该方法非常高效,可实现底物的完全转化,产物的高收率和可忽略的副产物,并且不需要柱色谱法纯化。温和的条件使该协议能够表现出出色的官能团兼容性。
  • An Efficient Synthesis of Terminal Allenes from Terminal 1-Alkynes
    作者:Jinqiang Kuang、Shengming Ma
    DOI:10.1021/jo802391x
    日期:2009.2.20
    We have developed a modified method for the synthesis of terminal allenes from terminal 1-alkyne: The reaction of 1-alkynes with 1.8 equiv of Cy2NH and 2.5 equiv of paraformaldehyde mediated by CuI (0.5 equiv) in refluxing dioxane may produce terminal allenes in much higher yields than the previously reported protocol and many functional groups such as mesylate, hydroxyl group, ether, amide, etc. may
    我们已经开发出一种从末端1-炔烃合成末端烯基的改良方法:在回流的二恶烷中,由CuI(0.5当量)介导的1-炔烃与1.8当量的Cy 2 NH和2.5当量的多聚甲醛的反应可能产生末端烯基与以前报道的方案相比,其收率要高得多,并且可以容忍许多官能团,例如甲磺酸酯,羟基,醚,酰胺等。
  • [EN] CDK2 DEGRADERS AND USES THEREOF<br/>[FR] AGENTS DE DÉGRADATION DE CDK2 ET LEURS UTILISATIONS
    申请人:KYMERA THERAPEUTICS INC
    公开号:WO2022236058A1
    公开(公告)日:2022-11-10
    The present invention provides compounds, compositions thereof, and methods of using the same.
    本发明提供了化合物、其组合物以及使用方法。
  • IRAK degraders and uses thereof
    申请人:Kymera Therapeutics, Inc.
    公开号:US10874743B2
    公开(公告)日:2020-12-29
    The present invention provides compounds, compositions thereof, and methods of using the same.
    本发明提供了化合物、其组合物以及使用方法。
查看更多